IGC PHARMA, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-03-31 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-12-31 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $0.00.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-06-30 was $18.00K.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $18.00K, a 90.58% decline from fiscal 2018.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $191.00K, a 47.13% increase from fiscal 2017.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $129.82K, a 37.75% increase from fiscal 2016.
- IGC PHARMA, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $94.24K, a 53.81% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-13 | $18.00K 10-K · filed 2020-07-13 |
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | |
| 2018-06-30 | $18.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $191.00K 10-K · filed 2019-06-14 | |
| 2017-03-31 | $129.82K 10-K · filed 2018-06-21 | |
| 2016-03-31 | $94.24K 10-K · filed 2017-07-14 | |
| 2015-03-31 | $204.03K 10-K · filed 2016-07-14 | |
| 2014-03-31 | $270.52K 10-K · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |